Constipation (opioid-induced) - naloxegol: committee papers

01 Pre-Meeting Briefing prepared by NICE
02 Submission from the technology manufacturer - AstraZeneca
03 NICE request to the manufacturer for clarification on their submission
04 Manufacturer clarification response
05 Clinical expert personal perspective - DAVIES
06 Clinical expert personal perspective - FARQUHAR-SMITH
07 Clinical expert personal perspective - IRWIN
08 Evidence Review Group report prepared by Kleijnen Systematic Reviews Ltd
09 Evidence Review Group report erratum
10 Manufacturer factual accuracy check of Evidence Review Group report
11 Evidence Review Group addendum MTC exploratory analyses

This page was last updated: 27 May 2015